日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells

暂时抑制 53BP1 可增加人类造血干细胞和祖细胞中的靶向整合频率

Ron Baik, M Kyle Cromer, Steve E Glenn, Christopher A Vakulskas, Kay O Chmielewski, Amanda M Dudek, William N Feist, Julia Klermund, Suzette Shipp, Toni Cathomen, Daniel P Dever, Matthew H Porteus

Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice

Cas9-AAV6 基因校正自体 HSC 中的 β 珠蛋白可改善小鼠镰状细胞病红细胞生成

Adam C Wilkinson #, Daniel P Dever #, Ron Baik, Joab Camarena, Ian Hsu, Carsten T Charlesworth, Chika Morita, Hiromitsu Nakauchi, Matthew H Porteus0

The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells

TRACE-Seq 方法可追踪重组等位基因并识别基因靶向人造血干细胞的克隆重建动态。

Rajiv Sharma # ,Daniel P Dever # ,Ciaran M Lee # ,Armon Azizi # ,Yidan Pan ,Joab Camarena ,Thomas Köhnke ,Gang Bao ,Matthew H Porteus ,Ravindra Majeti

Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency

造血干细胞中临床相关的基因编辑用于治疗丙酮酸激酶缺乏症

Sara Fañanas-Baquero, Oscar Quintana-Bustamante, Daniel P Dever, Omaira Alberquilla, Rebeca Sanchez-Dominguez, Joab Camarena, Isabel Ojeda-Perez, Mercedes Dessy-Rodriguez, Rolf Turk, Mollie S Schubert, Annalisa Lattanzi, Liwen Xu, Jose L Lopez-Lorenzo, Paola Bianchi, Juan A Bueren, Mark A Behlke, Ma

Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination

通过 CRISPR-Cas9 RNP 和 AAV6 供体介导的同源重组对人类多能干细胞进行高效、无标记的基因组编辑

Renata M Martin, Kazuya Ikeda, M Kyle Cromer, Nobuko Uchida, Toshinobu Nishimura, Rosa Romano, Andrew J Tong, Viktor T Lemgart, Joab Camarena, Mara Pavel-Dinu, Camille Sindhu, Volker Wiebking, Sriram Vaidyanathan, Daniel P Dever, Rasmus O Bak, Anders Laustsen, Benjamin J Lesch, Martin R Jakobsen, Vi

Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease

高效编辑患者来源的造血干细胞和祖细胞中的 β-珠蛋白基因以治疗镰状细胞病

So Hyun Park, Ciaran M Lee, Daniel P Dever, Timothy H Davis, Joab Camarena, Waracharee Srifa, Yankai Zhang, Alireza Paikari, Alicia K Chang, Matthew H Porteus, Vivien A Sheehan, Gang Bao

CRISPR/Cas9 Genome Engineering in Engraftable Human Brain-Derived Neural Stem Cells

可移植人脑神经干细胞的 CRISPR/Cas9 基因组工程

Daniel P Dever, Samantha G Scharenberg, Joab Camarena, Eric J Kildebeck, Joseph T Clark, Renata M Martin, Rasmus O Bak, Yuming Tang, Monika Dohse, Johannes A Birgmeier, Karthik A Jagadeesh, Gill Bejerano, Ann Tsukamoto, Natalia Gomez-Ospina, Nobuko Uchida, Matthew H Porteus

A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells

以核糖核蛋白复合物形式传递的高保真 Cas9 突变体可在人类造血干细胞和祖细胞中进行有效的基因编辑

Christopher A Vakulskas, Daniel P Dever, Garrett R Rettig, Rolf Turk, Ashley M Jacobi, Michael A Collingwood, Nicole M Bode, Matthew S McNeill, Shuqi Yan, Joab Camarena, Ciaran M Lee, So Hyun Park, Volker Wiebking, Rasmus O Bak, Natalia Gomez-Ospina, Mara Pavel-Dinu, Wenchao Sun, Gang Bao, Matthew H

CRISPR/Cas9 genome editing in human hematopoietic stem cells

利用CRISPR/Cas9技术对人类造血干细胞进行基因组编辑

Rasmus O Bak ,Daniel P Dever ,Matthew H Porteus

Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells

CD34+造血干细胞和祖细胞中基于CRISPR/Cas9-AAV6的基因组编辑的全局转录反应

M Kyle Cromer ,Sriram Vaidyanathan ,Daniel E Ryan ,Bo Curry ,Anne Bergstrom Lucas ,Joab Camarena ,Milan Kaushik ,Sarah R Hay ,Renata M Martin ,Israel Steinfeld ,Rasmus O Bak ,Daniel P Dever ,Ayal Hendel ,Laurakay Bruhn ,Matthew H Porteus